Skip to content

Teva Pharmaceutical Industries

US · TEVA #471 by market cap Listed 1970
39.23 +0.69 +1.79%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 38.46 -0.21%
After-hours 39.23 0.00%
Overnight 38.78 +0.62%
44.5030.1539.232026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on TEVA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +34.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 2.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 91.2x Better than 4%
Forward P/E 25.5x Better than 24%
Price / Sales 2.7x Better than 47%
P/E vs own 5-yr range 99th pctl Better than 4%
Growth C-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 5.0% Better than 46%
Net income CAGR (3Y) -36.2% Better than 9%
Free cash flow CAGR (3Y) 3.3% Better than 42%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 51.8% Better than 65%
Operating margin 22.9% Better than 81%
Net margin 8.2% Better than 54%
Return on equity 21.2% Better than 79%
Return on invested capital 8.7% Better than 63%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 5.1% Better than 83%
6-month return 15.1% Better than 78%
12-month return (ex latest month) 62.8% Better than 88%
Distance below 52-week high 12.0% Better than 79%
Financial Health D

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.0x Better than 21%
Debt to assets 42.0% Better than 24%
Interest coverage 2.3x Better than 39%
Free cash flow / net income 81.4% Better than 27%
Analyst View B+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 31.4% Better than 51%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -11.84%
1M -3.97%
3M +6.57%
6M +14.31%
YTD +25.70%
1Y +61.57%
3Y +315.13%
5Y +341.78%

Key statistics

Price & volume

Prev close
38.54
Open
38.46
Day range
38.30 - 39.91
Avg price
39.31
Volume
6.81M
Turnover
267.66M
Amplitude
4.18%
52-week range
24.34 - 44.57

Valuation

P/E
32.42
P/E (TTM)
91.23
P/B
5.74
EPS
1.21
Net profit
1.41B
Net assets
7.98B

Share structure

Market cap
45.77B
Float cap
42.78B
Shares out
1.17B

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 74% of range
24.34 44.57

12.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-238.03M net over the window

Short interest

Shares short
27.74M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Teva Pharmaceutical Industries (TEVA)?

Teva Pharmaceutical Industries last traded at 39.23. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Teva Pharmaceutical Industries's market cap?

About 45.77B.

What is the P/E ratio of Teva Pharmaceutical Industries?

The trailing twelve-month P/E is 91.23. The Valuation tab shows it against the stock's own five-year range.

Does Teva Pharmaceutical Industries pay a dividend?

Teva Pharmaceutical Industries does not currently pay a regular dividend.

Is Teva Pharmaceutical Industries a buy according to analysts?

The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 51.54, which implies 31.4% upside from the current price. This is not investment advice.

What is Teva Pharmaceutical Industries's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Teva Pharmaceutical Industries a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:01:26 · For reference only, not investment advice and not tailored to your situation.

Teva Pharmaceutical Industries discussion 0 comments

Add a comment